Our understanding of nociceptive processing and of plastic changes after pe
rsistent noxious input has increased immensely within the last two decades.
It is now clear that long-lasting noxious stimulation or damage to the ner
vous system give rise to a neuronal hyperexcitability and that this sensiti
sation of the nervous system plays an important role for development and ma
intenance of chronic pain. The manifestations of such hyperexcitability are
numerous and include among others: increased neuronal response to a suprat
hreshold stimulus, expansion of the peripheral areas from where a central n
eurone can be activated and the recruitment of previous non-responding noci
ceptive neurones. Furthermore, it has been possible to modulate this neuron
al hyperexcitability by the discovery of molecular targets for pain, by seq
uencing DNA of ion channels and receptors and by development of new molecul
es that exert their effects on these molecular targets. The changes in resp
onsiveness appear to be partly time and intensity dependent and partly depe
ndent on the cause of injury. Whereas relatively short-lasting and moderate
noxious input leads to reversible plastic changes, more intense and long-l
asting noxious stimulation implies a risk for persistent and more profound
alterations in transmitters, receptors, ion channels and in neuronal connec
tivity. Despite the explosion of new knowledge in pain processing and in mo
lecular background for neuroplasticity, this progress has unfortunately not
resulted in a corresponding improvement of our ability to treat chronic pa
in. The number of patients with chronic unrelieved pain is still high and n
ewer types of treatment have so far not resulted in a substantially better
treatment. Nevertheless, there is now an ongoing systematic research in whi
ch chronic pain conditions are assessed in a fashion so that mechanisms und
erlying pain can be dissected. Moreover, controlled clinical trials togethe
r with systematic reviews are carried out which in the future should permit
formulation of treatment algorithms for chronic pain. Finally, it is likel
y that the development of new specific types of treatment will show efficac
y if they are evaluated and analysed not on the global pain experience, but
more specifically on those targets and elements of the pain experience the
y are aimed to deal with.